New Targeted Therapies in Spondyloarthritis: What Are the Limits?

Immunotherapy - United Kingdom
doi 10.2217/imt-2019-0007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd